Catalyst Pharmaceuticals (NASDAQ:CPRX) and Inspyr Therapeutics (OTCMKTS:NSPX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Profitability This table compares Catalyst Pharmaceuticals and Inspyr Therapeutics’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on...
Read Full StoryRelated
, 10min
0
Disease-prevention-and-treatment
Asia Today: China sees virus outbreaks across its northeast
, 10min
0
Disease-prevention-and-treatment
World Health Assembly calls for urgent action on prevention and control of meningitis
, 11min
0
Disease-prevention-and-treatment
Asia Today: China sees virus outbreaks across its northeast
, 12min
0
Disease-prevention-and-treatment
Asia Today: China sees virus outbreaks across its northeast
, 13min
0
Disease-prevention-and-treatment
Asia Today: China sees virus outbreaks across its northeast
, 13min
0
Disease-prevention-and-treatment
Asia Today: China sees virus outbreaks across its northeast
, 14min
0
Disease-prevention-and-treatment
Panel findings back PM's criticism of World Health Organisation
, 14min
0
Disease-prevention-and-treatment
500 people vaccinated, 300 had appointments at Madison Co. Health Dept.
, 15min
0